CLOV logo

CLOV EBITDA

Annual EBITDA:

-$44.94M+$162.70M(+78.36%)
December 31, 2024

Summary

  • As of today, CLOV annual EBITDA is -$44.94 million, with the most recent change of +$162.70 million (+78.36%) on December 31, 2024.
  • During the last 3 years, CLOV annual EBITDA has risen by +$524.66 million (+92.11%).
  • CLOV annual EBITDA is now at all-time high.

Performance

CLOV EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLOVincome statement metrics

Quarterly EBITDA:

-$23.97M-$13.81M(-135.82%)
September 30, 2025

Summary

  • As of today, CLOV quarterly EBITDA is -$23.97 million, with the most recent change of -$13.81 million (-135.82%) on September 30, 2025.
  • Over the past year, CLOV quarterly EBITDA has dropped by -$15.53 million (-183.81%).
  • CLOV quarterly EBITDA is now -190.21% below its all-time high of $26.57 million, reached on September 30, 2020.

Performance

CLOV Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLOVincome statement metrics

TTM EBITDA:

-$56.08M-$15.53M(-38.28%)
September 30, 2025

Summary

  • As of today, CLOV TTM EBITDA is -$56.08 million, with the most recent change of -$15.53 million (-38.28%) on September 30, 2025.
  • Over the past year, CLOV TTM EBITDA has increased by +$34.17 million (+37.86%).
  • CLOV TTM EBITDA is now -281.55% below its all-time high of $30.89 million, reached on September 30, 2020.

Performance

CLOV TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLOVincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CLOV EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+78.4%-183.8%+37.9%
3Y3 Years+92.1%+67.8%+87.2%
5Y5 Years+86.1%-190.2%-281.6%

CLOV EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+92.1%-419.6%+69.1%-145.0%+87.2%
5Y5-Yearat high+92.1%-190.2%+92.4%-281.6%+90.8%
All-TimeAll-Timeat high+92.1%-190.2%+92.4%-281.6%+90.8%

CLOV EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
-$23.97M(-135.8%)
-$56.08M(-38.3%)
Jun 2025
-
-$10.16M(-1158.0%)
-$40.56M(-77.2%)
Mar 2025
-
-$808.00K(+96.2%)
-$22.89M(+48.1%)
Dec 2024
-$44.94M(+78.4%)
-$21.14M(-150.3%)
-$44.12M(+51.1%)
Sep 2024
-
-$8.45M(-212.6%)
-$90.25M(+21.4%)
Jun 2024
-
$7.50M(+134.0%)
-$114.86M(+23.6%)
Mar 2024
-
-$22.03M(+67.2%)
-$150.25M(+27.0%)
Dec 2023
-$207.63M(+17.6%)
-$67.27M(-103.5%)
-$205.82M(-48.6%)
Sep 2023
-
-$33.06M(-18.6%)
-$138.50M(+23.0%)
Jun 2023
-
-$27.88M(+64.1%)
-$179.90M(+29.6%)
Mar 2023
-
-$77.61M(>-9900.0%)
-$255.38M(-1.3%)
Dec 2022
-$252.03M
$55.00K(+100.1%)
-$252.03M(+42.5%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$74.46M(+28.0%)
-$438.03M(-10.2%)
Jun 2022
-
-$103.37M(-39.2%)
-$397.55M(+34.9%)
Mar 2022
-
-$74.26M(+60.1%)
-$610.44M(-7.2%)
Dec 2021
-$569.60M(-623.5%)
-$185.94M(-447.2%)
-$569.60M(-15.5%)
Sep 2021
-
-$33.98M(+89.3%)
-$493.30M(-14.0%)
Jun 2021
-
-$316.26M(-846.3%)
-$432.74M(-343.2%)
Mar 2021
-
-$33.42M(+69.5%)
-$97.64M(-24.0%)
Dec 2020
-$78.73M(+75.7%)
-$109.64M(-512.6%)
-$78.73M(-354.9%)
Sep 2020
-
$26.57M(+41.0%)
$30.89M(+615.5%)
Jun 2020
-
$18.85M(+229.9%)
$4.32M(+129.7%)
Mar 2020
-
-$14.51M(>-9900.0%)
-$14.53M(>-9900.0%)
Dec 2019
-$324.12M
-$17.60K
-$17.60K

FAQ

  • What is Clover Health Investments, Corp. annual EBITDA?
  • What is the all-time high annual EBITDA for Clover Health Investments, Corp.?
  • What is Clover Health Investments, Corp. annual EBITDA year-on-year change?
  • What is Clover Health Investments, Corp. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Clover Health Investments, Corp.?
  • What is Clover Health Investments, Corp. quarterly EBITDA year-on-year change?
  • What is Clover Health Investments, Corp. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Clover Health Investments, Corp.?
  • What is Clover Health Investments, Corp. TTM EBITDA year-on-year change?

What is Clover Health Investments, Corp. annual EBITDA?

The current annual EBITDA of CLOV is -$44.94M

What is the all-time high annual EBITDA for Clover Health Investments, Corp.?

Clover Health Investments, Corp. all-time high annual EBITDA is -$44.94M

What is Clover Health Investments, Corp. annual EBITDA year-on-year change?

Over the past year, CLOV annual EBITDA has changed by +$162.70M (+78.36%)

What is Clover Health Investments, Corp. quarterly EBITDA?

The current quarterly EBITDA of CLOV is -$23.97M

What is the all-time high quarterly EBITDA for Clover Health Investments, Corp.?

Clover Health Investments, Corp. all-time high quarterly EBITDA is $26.57M

What is Clover Health Investments, Corp. quarterly EBITDA year-on-year change?

Over the past year, CLOV quarterly EBITDA has changed by -$15.53M (-183.81%)

What is Clover Health Investments, Corp. TTM EBITDA?

The current TTM EBITDA of CLOV is -$56.08M

What is the all-time high TTM EBITDA for Clover Health Investments, Corp.?

Clover Health Investments, Corp. all-time high TTM EBITDA is $30.89M

What is Clover Health Investments, Corp. TTM EBITDA year-on-year change?

Over the past year, CLOV TTM EBITDA has changed by +$34.17M (+37.86%)
On this page